FEB 08, 2016 9:55 AM PST

Could a Blood Pressure Drug Help Children With Autism?

Autism is a neurodevelopmental disorder, which impairs communication and social interaction skills. The CDC reports that the disorder is on the rise, showing a 30% increase in the number of cases. While the debate has raged over whether or not the increase is due to actual new cases or better diagnostics, and research has focused on causes more than treatments, there might be new information from a study out of the University of Missouri.
A new study looked blood pressure medication for autism

The study conducted there looked at the blood pressure drug propranolol. David Beversdorf, MD, associate professor in the departments of radiology, neurology and psychological sciences at MU and the MU Thompson Center for Autism and Neurodevelopmental Disorders was the senior author of the study. In a press release  from MU he said,  “Propranolol was first reported to improve the language and sociability skills of individuals with autism in 1987, but it was not a randomized, controlled trial, and there has been little follow-up research on this drug in relation to autism. While its intended use is to treat high blood pressure, propranolol has been used off-label to treat performance anxiety for several years. However, this is the first study to show that a single dose of propranolol can improve the conversational reciprocity skills of individuals with autism.”
 
The study participants were 20 individuals with autism who were identified as patients at the MU Thompson Center. One group was given a 40 mg dose of the drug per day and the control group was given a placebo.
 
The study was double blind so patients did not know which pill they had received and neither did the researchers.  About an hour after administration, the researchers had a structured conversation with the participants, each time keeping the topic and intellectual level the same. The MU scientists scored the performance of each participant on six  social skills that were needed to maintain a two way conversation: staying on topic, sharing information, reciprocity or shared conversation, transitions or interruptions, nonverbal communication and maintaining eye contact. When the scores were tallied, the group that had received the medication did significantly better than those who had only received the placebo ()
 
Dr. Beversdorf stressed that this study was small and there needs to be more research on the effects after more than one dose, as well clinical trials to determine which patients might benefit the most of the medication. The study, “Effects of Propranolol on Conversational Reciprocity in Autism Spectrum Disorder: A Pilot, Double-blind, Single-dose Psychopharmacological Challenge Study,” was published in the journal Psychopharmacology. Check out the video below to learn more about autism spectrum disorders and how those on the spectrum manage their daily lives communicating with others and holding conversations.
 
 
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
New Insight Into Chronic Pain May Help Create Novel Therapeutics
Acute pain can progress to chronic pain, which can cause other problems including depression, loss of motivation and sensory dysfunction....
DEC 04, 2019
Neuroscience
DEC 04, 2019
Antibiotic Usage May Cause Parkinson's, Study Finds
A study from Helsinki University Hospital, Finland suggests that excessive usage of certain antibiotics may increase one’s risk of developing Parkins...
DEC 19, 2019
Drug Discovery & Development
DEC 19, 2019
Upcoming Psychedelic Cure for Addiction Derived from African Shrub
Every year, almost 70,000 people die from an overdose in the US. Now, a company called MindMed is testing a compound derived from ibogaine, a West African ...
JAN 28, 2020
Clinical & Molecular DX
JAN 28, 2020
Protein complex discovered as first biomarker of PTSD
  Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR) have identified a potential d...
FEB 12, 2020
Cannabis Sciences
FEB 12, 2020
Smoking Marijuana Leads to False Memory Formation
Smoking marijuana is known to make people forgetful. Now however, research has shown that smoking the substance may also make people remember things that n...
FEB 03, 2020
Neuroscience
FEB 03, 2020
Genetic Characterization of Bipolar Disorders, Major Depressive Disorder
Mood disorders, like Bipolar, Major Depressive Disorder, and Schizophrenia, among others, are difficult to define clinically.  Unlike disorders that a...
Loading Comments...